Ikapharmindo Putramas Past Earnings Performance
Past criteria checks 1/6
Ikapharmindo Putramas has been growing earnings at an average annual rate of 36.4%, while the Personal Products industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 16.7% per year. Ikapharmindo Putramas's return on equity is 6.3%, and it has net margins of 3.5%.
Key information
36.4%
Earnings growth rate
104.0%
EPS growth rate
| Personal Products Industry Growth | 11.4% |
| Revenue growth rate | -16.7% |
| Return on equity | 6.3% |
| Net Margin | 3.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Ikapharmindo Putramas makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 441,137 | 15,338 | 158,291 | 0 |
| 31 Dec 22 | 398,735 | 16,578 | 147,876 | 0 |
| 31 Dec 21 | 380,917 | 8,125 | 152,267 | 0 |
| 31 Dec 20 | 715,801 | 4,628 | 231,485 | 0 |
Quality Earnings: IKPM has high quality earnings.
Growing Profit Margin: IKPM's current net profit margins (3.5%) are lower than last year (4.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if IKPM's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: IKPM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IKPM had negative earnings growth (-7.5%) over the past year, making it difficult to compare to the Personal Products industry average (-6.2%).
Return on Equity
High ROE: IKPM's Return on Equity (6.3%) is considered low.